Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Novartis Invests $23 Billion to Expand U.S. Manufacturing and R&D Infrastructure
Novartis has announced plans to invest $23 billion over the next five years to strengthen its infrastructure in the United States The investment will ensure that all key medicines for US patients are manufactured domestically
Roche Expands U.S. Operations with $50 Billion Strategic Investment
Roche has announced a major investment of USD 50 billion in the United States, aimed at expanding its presence nationwide This move will strengthen Roches already substantial footprint in the US, which currently includes 13 manufacturing sites and 15 RD facilities across its Pharmaceuticals and Diagnostics divisions
Merck Announces $1 Billion Investment to Expand Vaccine Production Facility
Merck has inaugurated a cuttingedge vaccine manufacturing facility at its Durham, North Carolina site This $1 billion, 225,000squarefoot expansion is part of the companys broader initiative to enhance domestic production and research capabilities
Johnson & Johnson Sets $55B Investment Plan to Build Next-Gen Manufacturing Facilities
Johnson Johnson has announced plans to invest more than $55 billion in the United States over the next four years This marks a 25 percent increase compared to the companys previous fouryear investment period
CordenPharma Invests >€1 billion to Expand its Greenfield Facility
CordenPharma has announced plans to invest more than 1 billion over the next three years to build and expand peptide manufacturing facilities across Europe and the United States
AstraZeneca Invests C$820 Million to Advance Global Hub & Clinical Delivery
AstraZeneca, a global pharmaceutical company focused on developing innovative medicines, has announced an investment of C$820 million US$570 million in Canada This investment aims to create over 700 highly skilled jobs across various business areas and support
Orano Med Invests €250 Million in New Facility for Lead-212 Radioligand Therapy Precursors
Orano Med, part of the Orano Group and a leader in the development of targeted alpha therapies for cancer treatment, has marked the groundbreaking of its Advanced Thorium Extraction Facility ATEF in France
BioCentriq Invests $12 Million to Expand Princeton Manufacturing Facility
BioCentriq, a prominent contract development and manufacturing organization CDMO specializing in cell therapy, has signed a longterm lease agreement with National Business Parks for a cuttingedge manufacturing facility in Princeton, New Jersey This facility will become BioCentriqs new headquarters and is set to receive a $12M capital investment for...
AstraZeneca Invests $1.5 Billion to Construct Antibody Drug Conjugate Facility in Singapore
AstraZeneca has announced a significant investment of $15 billion to establish a stateoftheart manufacturing facility in Singapore, dedicated to the production of AntibodyDrug Conjugates ADCs This facility will play a pivotal role in advancing the companys efforts to deliver cuttingedge cancer treatments
Merck Invests €70 Million to Expand ADC Manufacturing for Cancer Therapies in the U.S.
Merck Company has announced 70 million to expand its ADC manufacturing capabilities in the USA This expansion will significantly increase capacity, tripling the current levels, and strengthen the companys contract development and manufacturing organization
